Journal article
Indolent lymphoma: Bendamustine, rituximab and acalabrutinib in Waldenstroms Macroglobulinemia (BRAWM)
Authors
Berinstein NL; Roos K; Klein G; McClure R; Forward N; Shafey M; Nikonova A; MacDonald D; Villa D; Sandhu I
Journal
Hematological Oncology, Vol. 41, No. S2, pp. 396–397
Publisher
Wiley
Publication Date
June 2023
DOI
10.1002/hon.3164_288
ISSN
0278-0232